Briefing From The Editor -- CRH Stock

By Tamara Parker • Monday, October 27 15:24 • Permanent Link

Large-cap Industrials company CRH PLC has moved 0.2% so far today on a volume of 1,943,431, compared to its average of 3,921,573. In contrast, the S&P 500 index moved 1.0%.

CRH PLC trades -9.63% away from its average analyst target price of $133.27 per share. The 24 analysts following the stock have set target prices ranging from $90.0 to $152.0, and on average have given CRH PLC a rating of buy.

Anyone interested in buying CRH should be aware of the facts below:

CRH PLC's current price is 102.5% above its Graham number of $59.49, which implies that at its current valuation it does not offer a margin of safety
CRH PLC has moved 27.3% over the last year, and the S&P 500 logged a change of 16.6%
Based on its trailing earnings per share of 4.77, CRH PLC has a trailing 12 month Price to Earnings (P/E) ratio of 25.2 while the S&P 500 average is 29.3
CRH has a forward P/E ratio of 19.8 based on its forward 12 month price to earnings (EPS) of $6.07 per share
Its Price to Book (P/B) ratio is 3.63 compared to its sector average of 2.89
CRH plc, together with its subsidiaries, provides building materials solutions in Ireland, the United States, the United Kingdom, rest of Europe, and internationally.
Based in Dublin, the company has 79,800 full time employees and a market cap of $80.73 Billion. CRH PLC currently returns an annual dividend yield of 1.2%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.